Clinical Trials Directory

Trials / Completed

CompletedNCT04158466

A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens

A Study to Evaluate the Safety and Efficacy of a Kalifilcon A Contact Lens for Daily Disposable Use

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
252 (actual)
Sponsor
Bausch & Lomb Incorporated · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study is to evaluate the safety and efficacy of a new silicone hydrogel daily disposable contact lens, kalifilcon A compared to the Bausch + Lomb Biotrue ONE day® daily disposable contact lens when worn by current soft contact lens wearers on a daily disposable wear basis.

Detailed description

Approximately 247 participants (494 eyes) will be enrolled in at approximately 20 investigative sites in the United States (US). A minimum of 20% of the randomized participants will be of Japanese descent (for example, both maternal and paternal grandparents born in Japan).

Conditions

Interventions

TypeNameDescription
DEVICEKalifilcon A Daily Disposable Contact LensesContact lens
DEVICEBiotrue ONEday Daily Disposable Contact LensesContact lens

Timeline

Start date
2019-05-31
Primary completion
2019-11-12
Completion
2019-11-12
First posted
2019-11-08
Last updated
2020-11-19
Results posted
2020-11-19

Locations

16 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04158466. Inclusion in this directory is not an endorsement.